Genetic polymorphisms and oxidative stress in heart failure

Congestive Heart Failure

Volumn 8, Issue 3, 2002, Pages

  Alameddine, Fadi M F ^a   Zafari, A Maziar ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; APOLIPOPROTEIN E; BETA ADRENERGIC RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN A RECEPTOR; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE;

CARDIOVASCULAR DISEASE; CELLULAR DISTRIBUTION; CORONARY ARTERY DISEASE; DIAGNOSTIC PROCEDURE; DISEASE PREDISPOSITION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART DILATATION; HEART FAILURE; HEREDITY; HUMAN; IDIOPATHIC DISEASE; ISCHEMIC HEART DISEASE; OXIDATIVE STRESS; REVIEW; RISK ASSESSMENT; STRUCTURE ACTIVITY RELATION;

EID: 0036084068     PISSN: 10797998     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-5299.2002.00719.x     Document Type: Review

References (68)

1. In vivo infusion of oxygen free radical substrates causes myocardial systolic, but not diastolic dysfunction
2. Evidence of oxidative stress in chronic heart failure in humans
3. Increased malondialdehyde in peripheral blood of patients with congestive heart failure
4. Increased oxidative stress in patients with congestive heart failure
5. Oxygen free radicals in volume overload heart failure
6. Gene expression of antioxidative enzymes in the human heart: Increased expression of catalase in the end-stage failing heart
7. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays
8. Leading the way using microarray: A more comprehensive approach for discovery of gene expression patterns
9. Molecular structure and organization of the human manganese superoxide dismutase gene
10. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease
11. Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese
12. 10-Fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain
13. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene
14. Nitric oxide attenuates cardiac myocyte contraction
15. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
16. Apoptosis in the failing human heart
17. Role of myocyte nitric oxide in beta-adrenergic hyporesponsiveness in heart failure
18. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: Role of enhanced vascular superoxide production
19. Expression of inducible nitric oxide synthase in human heart failure
20. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels
21. Association of extracellular-superoxide dismutase phenotype with the endothelial constitutive nitric oxide synthase polymorphism
22. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide
23. Asp298 variant of endothelial nitric oxide synthase (eNOS) and functional capacity in patients with heart failure
24. The endothelial nitric-oxide synthase-caveolin regulatory cycle
25. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides
26. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes
27. Apolipoprotein E epsilon4 allele as a genetic risk factor for left ventricular failure in homozygous beta-thalassemia
28. Apolipoprotein E genotype: Epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease
29. Role of platelet activating factor (PAF) in oxygen radical-induced cardiac dysfunction
30. Human plasma platelet-activating factor acetylhydrolase: Oxidatively fragmented phospholipids as substrates
31. Platelet-activating factor acetylhydrolase deficiency: A missense mutation near the active site of an anti-inflammatory phospholipase
32. Association of a G994→T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with genetic susceptibility to nonfamilial dilated cardiomyopathy in Japanese
33. Autooxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine and related compound toward CI300 neuroblastoma cells in vitro
34. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction
35. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: Progressive receptor down-regulation and subsensitivity to agonist response
36. Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus dilated cardiomyopathy
37. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF)
38. Cloning of the cDNA for the human beta1-adrenergic receptor
39. Beta1-adrenoceptor gene variations: A role in idiopathic dilated cardiomyopathy?
40. A novel polymorphism in the gene coding for the beta1-adrenergic receptor associated with survival in patients with heart failure
41. Polymorphic Gly389 (1 adrenergic receptors depress exercise capacity in heart failure
42. A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor
43. Mutations in the gene encoding for the beta2-adrenergic receptor in normal and asthmatic subjects
44. Myocardial signaling defects and impaired cardiac function of a human beta2-adrenergic receptor polymorphism expressed in transgenic mice
45. The Ile 164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure
46. Polymorphisms of the [beta]2-adrenergic receptor determine exercise capacity in patients with heart failure
47. Tissue-specific activation of cardiac angiotensin-converting enzyme in experimental heart failure
48. Comparative free radical scavenging action of angiotensin-converting enzyme inhibitors with and without the sulfhydryl radical
49. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after acute myocardial infarction. Result of the survival and enlargement trial
50. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
51. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy
52. Interrelationships among prostaglandins and vasoactive substances
53. Role of oxygen derived free radicals and metabolites in leukocyte dependent inflammatory reaction
54. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half of the variance of serum enzyme levels
55. Angiotensin-converting enzyme DD genotype in patients with ischaemic or dilated cardiomyopathy
56. Association of left ventricular systolic performance and cavity size with angiotensin-converting enzyme genotype in idiopathic dilated cardiomyopathy
57. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy
58. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure
59. Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure
60. The deletion polymorphism of the ACE gene is a determinant of accelerated autonomic imbalance in congestive heart failure
61. Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype
62. Myocardial endothelin: Does it play a role in myocardial failure?
63. Endothelin receptors in the failing and nonfailing human heart
64. Oxidative stress suppresses the endothelial secretion of endothelin
65. Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter
66. Identification of a genetic risk factor for idiopathic dilated cardiomyopathy: Involvement of a polymorphism in the endothelin receptor type A gene
67. Antioxidant effect of carvedilol and metoprolol in congestive heart failure